Management of portopulmonary hypertension: What is more important, PAH severity or liver disease severity?
- PMID: 32950270
- DOI: 10.1016/j.jhep.2020.07.024
Management of portopulmonary hypertension: What is more important, PAH severity or liver disease severity?
Conflict of interest statement
Conflicts of interest The authors have no conflicts of interest to declare. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Management of portopulmonary hypertension: What is more important, PAH severity or liver disease severity?".J Hepatol. 2021 Jan;74(1):238-239. doi: 10.1016/j.jhep.2020.08.026. Epub 2020 Sep 21. J Hepatol. 2021. PMID: 32972731 No abstract available.
Comment on
-
Portopulmonary hypertension in the current era of pulmonary hypertension management.J Hepatol. 2020 Jul;73(1):130-139. doi: 10.1016/j.jhep.2020.02.021. Epub 2020 Mar 5. J Hepatol. 2020. PMID: 32145258
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
